share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Dmytruk Mark E.

SEC announcement ·  Apr 5 04:42
Summary by Futu AI
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. [DNA], completed a series of transactions involving the company's Class A Common Stock. On April 1, 2024, Dmytruk acquired a total of 108,123 shares through the exercise of derivative securities. The following day, on April 2, 2024, he sold 51,169 shares in an open market transaction at a price of $1.05 per share, resulting in a total sale value of $53,727.45. After these transactions, Dmytruk's direct holdings in Ginkgo Bioworks totaled 865,079 shares.
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. [DNA], completed a series of transactions involving the company's Class A Common Stock. On April 1, 2024, Dmytruk acquired a total of 108,123 shares through the exercise of derivative securities. The following day, on April 2, 2024, he sold 51,169 shares in an open market transaction at a price of $1.05 per share, resulting in a total sale value of $53,727.45. After these transactions, Dmytruk's direct holdings in Ginkgo Bioworks totaled 865,079 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.